| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |